BRIDGEWAY CAPITAL MANAGEMENT, LLC - DURATA THERAPEUTICS INC ownership

DURATA THERAPEUTICS INC's ticker is DRTX and the CUSIP is 26658A107. A total of 59 filers reported holding DURATA THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of DURATA THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$966,000
-25.5%
76,1500.0%0.02%
-29.4%
Q2 2014$1,297,000
+26.5%
76,1500.0%0.03%
+17.2%
Q1 2014$1,025,000
+5.2%
76,1500.0%0.03%
-3.3%
Q4 2013$974,000
+41.6%
76,1500.0%0.03%
+30.4%
Q3 2013$688,000
+101.2%
76,150
+60.3%
0.02%
+64.3%
Q2 2013$342,00047,5000.01%
Other shareholders
DURATA THERAPEUTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 508,472$4,596,0003.19%
Broadfin Capital, LLC 383,227$3,464,0000.62%
Orbimed Advisors 1,785,714$16,143,0000.29%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 275,979$2,495,0000.12%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 1,188,571$10,745,0000.10%
Lenox Wealth Advisors, LLC 8,000$72,0000.07%
STONERIDGE INVESTMENT PARTNERS LLC 30,732$278,0000.06%
Loeb Offshore Management LP 19,621$177,0000.06%
Alyeska Investment Group, L.P. 100,000$904,0000.04%
PARADIGM ASSET MANAGEMENT CO LLC 25,000$226,000,0000.04%
View complete list of DURATA THERAPEUTICS INC shareholders